Product Code: RP-ID-10151849 |
Published Date: 21 Oct 2022 |
Region: NA |
Category: Healthcare & Pharmaceuticals |
Report ID: 10151849
Market Overview:
Global Immunoinformatics Industry Market Research 2030
"The global immunoinformatics market is expected to experience profitable growth due to a large number of applications in processing abundant human and biological genome sequencing data and the integration of computational and experimental methods. In addition, advances related to R&D activities are expected to promote market growth, including host-pathogen interactions in disease diagnosis and allergy prediction. Laboratory experiments and computer vaccination are expected to expand the scope of research activities in the immunoinformatics market.
In addition, the development of proteomics and genomics is expected to promote market growth during the forecast period. It is expected that the development of personalized medicine related to immunoinformatics and systems biology will make important progress in the next seven years.
Due to the incremental development of high-throughput molecular biology technology and the impact of drug delivery through computational methods, the market will grow at a faster rate during the forecast period. Major improvements and coordination in the field of immunoinformatics and immunologists and bioinformatics Home’s efforts to build an integrated platform are expected to increase market growth during the forecast period.
In addition, the continuous emergence of new technologies in the fields of immunoproteomics and immunogenomics is one of the key success factors for the growth of the immunoinformatics market. Through routine immunoinformatics, tropical and emerging infectious diseases are becoming more and more popular, and people are paying more and more attention to the key determinants of the immune system.
This method is expected to boost the market during the forecast period. Increasing funds for the rapid development of new vaccines through cooperation between the vaccine and immunotherapy centers and the defense threat reduction industry and other academic and industry organizations will help promote the development of the field of immunoinformatics. The global market for immunoinformatics is segmented according to the types of applications and databases. In addition, immunoinformatics has been applied in reverse vaccination, cancer diagnosis and treatment, and immune system modeling.
The types of databases analyzed in this field include the International Immunogenetics System, Immune Epitope Database and Analysis Resource Database, Immune Epitope Ontology and Allergy Prediction. The high success rate and error-free reliable results achieved by predicting machine learning technologies including artificial neural networks and support vector machines will actively promote market growth. North America, Asia Pacific, Europe, MEA and Latin America are the key areas of the immunoinformatics market.
In 2020, North America became one of the largest markets due to the existence of critical success factors, such as complex infrastructure related to rigorous R&D procedures performed in collaboration with doctors and scientists. In addition, the incidence of chronic diseases is getting higher and higher, and the demand for costs is also increasing. Accurate and effective vaccines that can effectively curb these diseases are expected to drive market growth, and the increasing recognition of the National Institutes of Health is expected to promote research critical to development. Vaccines promote the growth of the immunoinformatics market.
The major players in promoting research activities and addressing non-commercial disease epidemics are expected to increase the demand for the immunoinformatics market. For example, a successful collaboration between a pharmaceutical company and IMGT to develop new products for infectious diseases. In addition, the Department of Defense (DOD) and NIH, which are very interested in vaccine-related research, are currently funding biological defense vaccine projects.
For example, iCubed is currently cooperating with NIH to research and design translational vaccines for emerging infectious diseases; however, due to the infrastructure of research activities Facilities have been improved and the Asia-Pacific region is expected to become the fastest-growing part of the region. Favorable government initiatives have triggered demand for new therapies and research activities to improve production processes to effectively curb the increasing prevalence of various diseases such as diabetes, cancer, and HIV, which are expected to drive market growth. EpiVax Inc., Novozymes Biopharma, ioGenetics LLC, International Vaccine Association and IMGT. Continuous R&D activities and modifications in molecular process engineering corresponding to obtaining more precise and high-performance results are some of the strategic initiatives implemented by these participants. The collaboration between these participants addresses the need for current technology in research activities and is expected to increase the demand for new therapies and vaccines."
Related Reports
Proof of Quality & Reliability
